Hjem › Kronisk myelogen leukemi › Washington › Seattle
Kliniske studier for Kronisk myelogen leukemi i Seattle, WA
11 studier for Kronisk myelogen leukemi søker deltakere på steder i og rundt Seattle (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- og 1 flere
Study of Olverembatinib (HQP1351) in Patients With CML-CP
RekruttererFase 3
- Ascentage Investigative Site #1806, Seattle
- Ascentage Investigative Site #1510, Seattle
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
RekruttererFase 2
- Seattle Childrens Hospital, Seattle
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
RekruttererFase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekruttererObservasjonsstudie
- Fred Hutchinson Cancer Research Center, Seattle
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Fred Hutch/University of Washington Cancer Consortium, Seattle
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
RekruttererFase 1
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
RekruttererFase 2
- Fred Hutchinson Cancer Center, Seattle
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
RekruttererFase 1/2
- Fred Hutchinson Cancer Center, Seattle
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RekruttererFase 1
- Fred Hutchinson Cancer Research Center, Seattle
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
RekruttererFase 1
- Fred Hutchinson Cancer Center, Seattle
Kronisk myelogen leukemi-studier i andre byer
- Houston, TX18 studier
- New York City, NY11 studier
- Detroit, MI6 studier
- Birmingham, AL6 studier
- Philadelphia, PA6 studier
- Chicago, IL6 studier
- Baldwin Park, CA6 studier
- Portland, OR6 studier
- Nashville, TN5 studier
- Columbus, OH5 studier
- Milwaukee, WI5 studier
- Baltimore, MD5 studier
Andre studier i Seattle
- Ikke-småcellet lungekreft53 studier
- Kreft (alle typer)49 studier
- Prostatakreft42 studier
- Akut myelogen leukemi40 studier
- Brystkreft39 studier
- Metastatisk kreft39 studier
- Kolorektal kreft34 studier
- Lungekreft33 studier
- Eggstokkreft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukemi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.